COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

LDN_Study_Extended_BUDs_and_More_from_PCCA_Science.png

Yi Liu, PCCA Research Pharmacist, provides an exciting update regarding new therapies, the extension of beyond-use dates (BUDs) for compounding formulations, evaluating compounding equipment and a whole lot more in this PCCA Science Update!

PCCA Blog - 2018 - USP 795 and BUDs - Main Image 03.png

On March 30, 2018, the Compounding Expert Committee of the United States Pharmacopeial Convention published proposed revisions to USP chapter <795> Pharmaceutical Compounding – Nonsterile Preparations. The revised chapter was open to public comments until July 31, 2018, and is expected to become official on December 1, 2019. Major revisions to the chapter include, but are not limited to, the following: